Create a free PetfoodIndustry account to continue reading

Elanco to launch corporate venture capital platform

Elanco Ventures will invest to advance therapeutics, technologies and One Health solutions.

Elanco Animal Health Inc. plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health.

To be backed by a US$25 million multi-year commitment, Elanco Ventures will initially focus on strategic investments in therapeutic advancements and supportive technologies across the animal health sector.

“From pets to protein – the animal health industry has never been more relevant than it is today,” said Jeff Simmons, president and CEO of Elanco. “Innovation is happening outside of the boundaries of any single company. Elanco Ventures allows us to strategically leverage the startup landscape to expand our visibility into a range of emerging technologies that help us meet pet owners’ evolving expectation of care and the increasing global demand for protein.”